Edwards Lifesciences Research and Development Expenses 2010-2024 | EW

Edwards Lifesciences annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Edwards Lifesciences research and development expenses for the quarter ending September 30, 2024 were $0.253B, a 4.37% increase year-over-year.
  • Edwards Lifesciences research and development expenses for the twelve months ending September 30, 2024 were $1.135B, a 15.86% increase year-over-year.
  • Edwards Lifesciences annual research and development expenses for 2023 were $1.072B, a 13.39% increase from 2022.
  • Edwards Lifesciences annual research and development expenses for 2022 were $0.945B, a 4.66% increase from 2021.
  • Edwards Lifesciences annual research and development expenses for 2021 were $0.903B, a 18.72% increase from 2020.
Edwards Lifesciences Annual Research and Development Expenses
(Millions of US $)
2023 $1,072
2022 $945
2021 $903
2020 $761
2019 $753
2018 $622
2017 $553
2016 $442
2015 $383
2014 $347
2013 $323
2012 $291
2011 $246
2010 $204
2009 $176
Edwards Lifesciences Quarterly Research and Development Expenses
(Millions of US $)
2024-09-30 $253
2024-06-30 $273
2024-03-31 $285
2023-12-31 $324
2023-09-30 $243
2023-06-30 $244
2023-03-31 $261
2022-12-31 $232
2022-09-30 $234
2022-06-30 $251
2022-03-31 $229
2021-12-31 $233
2021-09-30 $238
2021-06-30 $225
2021-03-31 $207
2020-12-31 $196
2020-09-30 $196
2020-06-30 $182
2020-03-31 $187
2019-12-31 $194
2019-09-30 $196
2019-06-30 $192
2019-03-31 $171
2018-12-31 $163
2018-09-30 $162
2018-06-30 $154
2018-03-31 $143
2017-12-31 $147
2017-09-30 $143
2017-06-30 $134
2017-03-31 $129
2016-12-31 $115
2016-09-30 $113
2016-06-30 $113
2016-03-31 $102
2015-12-31 $98
2015-09-30 $101
2015-06-30 $98
2015-03-31 $86
2014-12-31 $84
2014-09-30 $88
2014-06-30 $89
2014-03-31 $86
2013-12-31 $79
2013-09-30 $84
2013-06-30 $81
2013-03-31 $80
2012-12-31 $75
2012-09-30 $74
2012-06-30 $74
2012-03-31 $69
2011-12-31 $61
2011-09-30 $62
2011-06-30 $65
2011-03-31 $59
2010-12-31 $56
2010-09-30 $53
2010-06-30 $51
2010-03-31 $45
2009-12-31 $88
2009-09-30 $45
2009-06-30 $43
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $41.404B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $194.739B 23.76
Intuitive Surgical (ISRG) United States $191.917B 100.34
Alcon (ALC) Switzerland $42.138B 28.19
IQVIA Holdings (IQV) United States $34.726B 19.13
IDEXX Laboratories (IDXX) United States $34.092B 40.15
DexCom (DXCM) United States $29.248B 44.05
STERIS (STE) Ireland $20.926B 24.09
Waters (WAT) United States $20.468B 30.26
SONOVA HOLDING (SONVY) Switzerland $20.297B 0.00
Hologic (HOLX) United States $18.250B 19.26
Fresenius Medical Care AG KGaA (FMS) Germany $12.969B 13.31
Sysmex ADR (SSMXY) Japan $12.688B 39.79
Globus Medical (GMED) United States $11.345B 28.73
Penumbra (PEN) United States $9.100B 89.14
Teleflex (TFX) United States $8.967B 14.30
Masimo (MASI) United States $8.754B 42.36
Glaukos (GKOS) United States $7.951B 0.00
PROCEPT BioRobotics (PRCT) United States $4.883B 0.00
Integer Holdings (ITGR) United States $4.479B 25.38
Veracyte (VCYT) United States $3.034B 91.05
Inari Medical (NARI) United States $2.984B 0.00
LivaNova (LIVN) United Kingdom $2.789B 16.10
TransMedics (TMDX) United States $2.783B 88.21
Nihon Kohden (NHNKY) Japan $2.293B 17.42
Elekta AB (EKTAY) Sweden $2.192B 17.86
Tandem Diabetes Care (TNDM) United States $1.830B 0.00
RxSight (RXST) United States $1.819B 0.00
Integra LifeSciences Holdings (IART) United States $1.766B 9.23
Alphatec Holdings (ATEC) United States $1.357B 0.00
Artivion (AORT) United States $1.129B 74.81
OPKO Health (OPK) United States $1.106B 0.00
Pulse Biosciences (PLSE) United States $1.048B 0.00
Paragon 28 (FNA) United States $0.879B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.818B 13.91
ORTHOFIX MEDICAL INC (OFIX) United States $0.716B 0.00
IRadimed (IRMD) United States $0.650B 35.10
OrthoPediatrics (KIDS) United States $0.589B 0.00
AxoGen (AXGN) United States $0.561B 0.00
Mesa Laboratories (MLAB) United States $0.542B 12.77
SiBone (SIBN) United States $0.517B 0.00
Treace Medical Concepts (TMCI) United States $0.483B 0.00
Pacific Biosciences Of California (PACB) United States $0.471B 0.00
Tactile Systems Technology (TCMD) United States $0.378B 20.48
Semler Scientific (SMLR) United States $0.337B 22.60
CVRx (CVRX) United States $0.326B 0.00
Delcath Systems (DCTH) United States $0.317B 0.00
ClearPoint Neuro (CLPT) United States $0.303B 0.00
NeuroPace (NPCE) United States $0.274B 0.00
AngioDynamics (ANGO) United States $0.273B 0.00
Inogen (INGN) United States $0.226B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
Accuray (ARAY) United States $0.185B 0.00
Atossa Genetics (ATOS) United States $0.161B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Nevro (NVRO) United States $0.159B 0.00
KORU Medical Systems (KRMD) United States $0.152B 0.00
Sensus Healthcare (SRTS) United States $0.137B 14.68
Spectral Diagnostics (EDTXF) Canada $0.112B 0.00
EDAP TMS S.A (EDAP) France $0.089B 0.00
WORK Medical Technology Group (WOK) China $0.088B 0.00
LENSAR (LNSR) United States $0.087B 0.00
908 Devices (MASS) United States $0.086B 0.00
Covalon Technologies (CVALF) Canada $0.078B 0.00
Monogram Orthopaedics (MGRM) United States $0.070B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.063B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
Vicarious Surgical (RBOT) United States $0.055B 0.00
Rapid Micro Biosystems (RPID) United States $0.047B 0.00
Accelerate Diagnostics (AXDX) United States $0.044B 0.00
Envoy Medical (COCH) United States $0.040B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Neuronetics (STIM) United States $0.023B 0.00
NexGel (NXGL) United States $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.015B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
Aspira Women's Health (AWH) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.010B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00